Cupping Therapy Kits
Cupping Therapy Kits market is segmented by region (country), players, by Type and by Application ... Read More
Global and United States Polio (Poliomyelitis) Vaccines Market Report & Forecast 2024-2031
1 Study Coverage
1.1 Polio (Poliomyelitis) Vaccines Product Introduction
1.2 Global Polio (Poliomyelitis) Vaccines Outlook 2017 VS 2022 VS 2028
1.2.1 Global Polio (Poliomyelitis) Vaccines Sales in US$ Million for the Year 2017-2028
1.2.2 Global Polio (Poliomyelitis) Vaccines Sales in Volume for the Year 2017-2028
1.3 United States Polio (Poliomyelitis) Vaccines Outlook 2017 VS 2022 VS 2028
1.3.1 United States Polio (Poliomyelitis) Vaccines Sales in US$ Million for the Year 2017-2028
1.3.2 United States Polio (Poliomyelitis) Vaccines Sales in Volume for the Year 2017-2028
1.4 Polio (Poliomyelitis) Vaccines Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4.1 The Market Share of United States Polio (Poliomyelitis) Vaccines in Global, 2017 VS 2022 VS 2028
1.4.2 The Growth Rate of Polio (Poliomyelitis) Vaccines Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.5 Polio (Poliomyelitis) Vaccines Market Dynamics
1.5.1 Polio (Poliomyelitis) Vaccines Industry Trends
1.5.2 Polio (Poliomyelitis) Vaccines Market Drivers
1.5.3 Polio (Poliomyelitis) Vaccines Market Challenges
1.5.4 Polio (Poliomyelitis) Vaccines Market Restraints
1.6 Study Objectives
1.7 Years Considered
2 Market by Type
2.1 Polio (Poliomyelitis) Vaccines Market Segment by Type
2.1.1 Inactivated Polio Vaccine (IPV)
2.1.2 Oral Polio Vaccine (OPV)
2.2 Global Polio (Poliomyelitis) Vaccines Market Size by Type
2.2.1 Global Polio (Poliomyelitis) Vaccines Sales in Value, by Type (2017, 2022 & 2028)
2.2.2 Global Polio (Poliomyelitis) Vaccines Sales in Volume, by Type (2017, 2022 & 2028)
2.2.3 Global Polio (Poliomyelitis) Vaccines Average Selling Price (ASP) by Type (2017, 2022 & 2028)
2.3 United States Polio (Poliomyelitis) Vaccines Market Size by Type
2.3.1 United States Polio (Poliomyelitis) Vaccines Sales in Value, by Type (2017, 2022 & 2028)
2.3.2 United States Polio (Poliomyelitis) Vaccines Sales in Volume, by Type (2017, 2022 & 2028)
2.3.3 United States Polio (Poliomyelitis) Vaccines Average Selling Price (ASP) by Type (2017, 2022 & 2028)
3 Market by Application
3.1 Polio (Poliomyelitis) Vaccines Market Segment by Application
3.1.1 Research & Academic Laboratories
3.1.2 Pharmaceutical & Biotechnology Companies
3.1.3 Others
3.2 Global Polio (Poliomyelitis) Vaccines Market Size by Application
3.2.1 Global Polio (Poliomyelitis) Vaccines Sales in Value, by Application (2017, 2022 & 2028)
3.2.2 Global Polio (Poliomyelitis) Vaccines Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 Global Polio (Poliomyelitis) Vaccines Average Selling Price (ASP) by Application (2017, 2022 & 2028)
3.3 United States Polio (Poliomyelitis) Vaccines Market Size by Application
3.3.1 United States Polio (Poliomyelitis) Vaccines Sales in Value, by Application (2017, 2022 & 2028)
3.3.2 United States Polio (Poliomyelitis) Vaccines Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 United States Polio (Poliomyelitis) Vaccines Average Selling Price (ASP) by Application (2017, 2022 & 2028)
4 Global Polio (Poliomyelitis) Vaccines Competitor Landscape by Company
4.1 Global Polio (Poliomyelitis) Vaccines Market Size by Company
4.1.1 Top Global Polio (Poliomyelitis) Vaccines Manufacturers Ranked by Revenue (2021)
4.1.2 Global Polio (Poliomyelitis) Vaccines Revenue by Manufacturer (2017-2022)
4.1.3 Global Polio (Poliomyelitis) Vaccines Sales by Manufacturer (2017-2022)
4.1.4 Global Polio (Poliomyelitis) Vaccines Price by Manufacturer (2017-2022)
4.2 Global Polio (Poliomyelitis) Vaccines Concentration Ratio (CR)
4.2.1 Polio (Poliomyelitis) Vaccines Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Polio (Poliomyelitis) Vaccines in 2021
4.2.3 Global Polio (Poliomyelitis) Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Polio (Poliomyelitis) Vaccines Manufacturing Base Distribution, Product Type
4.3.1 Global Polio (Poliomyelitis) Vaccines Manufacturers, Headquarters and Distribution of Producing Region
4.3.2 Manufacturers Polio (Poliomyelitis) Vaccines Product Type
4.3.3 Date of International Manufacturers Enter into Polio (Poliomyelitis) Vaccines Market
4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
4.5 United States Polio (Poliomyelitis) Vaccines Market Size by Company
4.5.1 Top Polio (Poliomyelitis) Vaccines Players in United States, Ranked by Revenue (2021)
4.5.2 United States Polio (Poliomyelitis) Vaccines Revenue by Players (2020, 2021 & 2022)
4.5.3 United States Polio (Poliomyelitis) Vaccines Sales by Players (2020, 2021 & 2022)
5 Global Polio (Poliomyelitis) Vaccines Market Size by Region
5.1 Global Polio (Poliomyelitis) Vaccines Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Polio (Poliomyelitis) Vaccines Market Size in Volume by Region (2017-2028)
5.2.1 Global Polio (Poliomyelitis) Vaccines Sales in Volume by Region: 2017-2022
5.2.2 Global Polio (Poliomyelitis) Vaccines Sales in Volume Forecast by Region (2023-2028)
5.3 Global Polio (Poliomyelitis) Vaccines Market Size in Value by Region (2017-2028)
5.3.1 Global Polio (Poliomyelitis) Vaccines Sales in Value by Region: 2017-2022
5.3.2 Global Polio (Poliomyelitis) Vaccines Sales in Value by Region: 2023-2028
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Polio (Poliomyelitis) Vaccines Market Size YoY Growth 2017-2028
6.1.2 North America Polio (Poliomyelitis) Vaccines Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Polio (Poliomyelitis) Vaccines Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Polio (Poliomyelitis) Vaccines Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe Polio (Poliomyelitis) Vaccines Market Size YoY Growth 2017-2028
6.3.2 Europe Polio (Poliomyelitis) Vaccines Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Polio (Poliomyelitis) Vaccines Market Size YoY Growth 2017-2028
6.4.2 Latin America Polio (Poliomyelitis) Vaccines Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Polio (Poliomyelitis) Vaccines Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Polio (Poliomyelitis) Vaccines Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 U.A.E
7 Company Profiles
7.1 Sanofi
7.1.1 Sanofi Corporation Information
7.1.2 Sanofi Description and Business Overview
7.1.3 Sanofi Polio (Poliomyelitis) Vaccines Sales, Revenue and Gross Margin (2017-2022)
7.1.4 Sanofi Polio (Poliomyelitis) Vaccines Products Offered
7.1.5 Sanofi Recent Development
7.2 GSK
7.2.1 GSK Corporation Information
7.2.2 GSK Description and Business Overview
7.2.3 GSK Polio (Poliomyelitis) Vaccines Sales, Revenue and Gross Margin (2017-2022)
7.2.4 GSK Polio (Poliomyelitis) Vaccines Products Offered
7.2.5 GSK Recent Development
7.3 Bibcol
7.3.1 Bibcol Corporation Information
7.3.2 Bibcol Description and Business Overview
7.3.3 Bibcol Polio (Poliomyelitis) Vaccines Sales, Revenue and Gross Margin (2017-2022)
7.3.4 Bibcol Polio (Poliomyelitis) Vaccines Products Offered
7.3.5 Bibcol Recent Development
7.4 Serum Institute
7.4.1 Serum Institute Corporation Information
7.4.2 Serum Institute Description and Business Overview
7.4.3 Serum Institute Polio (Poliomyelitis) Vaccines Sales, Revenue and Gross Margin (2017-2022)
7.4.4 Serum Institute Polio (Poliomyelitis) Vaccines Products Offered
7.4.5 Serum Institute Recent Development
7.5 Tiantan Biological
7.5.1 Tiantan Biological Corporation Information
7.5.2 Tiantan Biological Description and Business Overview
7.5.3 Tiantan Biological Polio (Poliomyelitis) Vaccines Sales, Revenue and Gross Margin (2017-2022)
7.5.4 Tiantan Biological Polio (Poliomyelitis) Vaccines Products Offered
7.5.5 Tiantan Biological Recent Development
7.6 IMBCA
7.6.1 IMBCA Corporation Information
7.6.2 IMBCA Description and Business Overview
7.6.3 IMBCA Polio (Poliomyelitis) Vaccines Sales, Revenue and Gross Margin (2017-2022)
7.6.4 IMBCA Polio (Poliomyelitis) Vaccines Products Offered
7.6.5 IMBCA Recent Development
7.7 Panacea Biotec Ltd
7.7.1 Panacea Biotec Ltd Corporation Information
7.7.2 Panacea Biotec Ltd Description and Business Overview
7.7.3 Panacea Biotec Ltd Polio (Poliomyelitis) Vaccines Sales, Revenue and Gross Margin (2017-2022)
7.7.4 Panacea Biotec Ltd Polio (Poliomyelitis) Vaccines Products Offered
7.7.5 Panacea Biotec Ltd Recent Development
7.8 Bio-Med
7.8.1 Bio-Med Corporation Information
7.8.2 Bio-Med Description and Business Overview
7.8.3 Bio-Med Polio (Poliomyelitis) Vaccines Sales, Revenue and Gross Margin (2017-2022)
7.8.4 Bio-Med Polio (Poliomyelitis) Vaccines Products Offered
7.8.5 Bio-Med Recent Development
7.9 Halfkin Bio-Pharmaceuticals
7.9.1 Halfkin Bio-Pharmaceuticals Corporation Information
7.9.2 Halfkin Bio-Pharmaceuticals Description and Business Overview
7.9.3 Halfkin Bio-Pharmaceuticals Polio (Poliomyelitis) Vaccines Sales, Revenue and Gross Margin (2017-2022)
7.9.4 Halfkin Bio-Pharmaceuticals Polio (Poliomyelitis) Vaccines Products Offered
7.9.5 Halfkin Bio-Pharmaceuticals Recent Development
8 Industry Chain and Sales Channels Analysis
8.1 Polio (Poliomyelitis) Vaccines Industry Chain Analysis
8.2 Polio (Poliomyelitis) Vaccines Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Polio (Poliomyelitis) Vaccines Distributors
8.3 Polio (Poliomyelitis) Vaccines Production Mode & Process
8.4 Polio (Poliomyelitis) Vaccines Sales and Marketing
8.4.1 Polio (Poliomyelitis) Vaccines Sales Channels
8.4.2 Polio (Poliomyelitis) Vaccines Distributors
8.5 Polio (Poliomyelitis) Vaccines Customers
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
Table 1. Polio (Poliomyelitis) Vaccines CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
Table 2. Polio (Poliomyelitis) Vaccines Market Trends
Table 3. Polio (Poliomyelitis) Vaccines Market Drivers
Table 4. Polio (Poliomyelitis) Vaccines Market Challenges
Table 5. Polio (Poliomyelitis) Vaccines Market Restraints
Table 6. Global Polio (Poliomyelitis) Vaccines Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 7. United States Polio (Poliomyelitis) Vaccines Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 8. Global Polio (Poliomyelitis) Vaccines Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 9. United States Polio (Poliomyelitis) Vaccines Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 10. Top Polio (Poliomyelitis) Vaccines Manufacturers in Global Market, Ranking by Revenue (2021)
Table 11. Global Polio (Poliomyelitis) Vaccines Revenue by Manufacturer, (US$ Million), 2017-2022
Table 12. Global Polio (Poliomyelitis) Vaccines Revenue Share by Manufacturer, 2017-2022
Table 13. Global Polio (Poliomyelitis) Vaccines Sales by Manufacturer, (K Units), 2017-2022
Table 14. Global Polio (Poliomyelitis) Vaccines Sales Share by Manufacturer, 2017-2022
Table 15. Global Polio (Poliomyelitis) Vaccines Price by Manufacturer (2017-2022) & (USD/Unit)
Table 16. Global Polio (Poliomyelitis) Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 17. Global Polio (Poliomyelitis) Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Polio (Poliomyelitis) Vaccines as of 2021)
Table 18. Top Players of Polio (Poliomyelitis) Vaccines in Global Market, Headquarters and Distribution of Producing Region
Table 19. Manufacturers Polio (Poliomyelitis) Vaccines Product Type
Table 20. Date of International Manufacturers Enter into Polio (Poliomyelitis) Vaccines Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Top Polio (Poliomyelitis) Vaccines Players in United States Market, Ranking by Revenue (2021)
Table 23. United States Polio (Poliomyelitis) Vaccines Revenue by Players, (US$ Million), 2020, 2021 & 2022
Table 24. United States Polio (Poliomyelitis) Vaccines Revenue Share by Players, 2020, 2021 & 2022
Table 25. United States Polio (Poliomyelitis) Vaccines Sales by Players, (K Units), 2020, 2021 & 2022
Table 26. United States Polio (Poliomyelitis) Vaccines Sales Share by Players, 2020, 2021 & 2022
Table 27. Global Polio (Poliomyelitis) Vaccines Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
Table 28. Global Polio (Poliomyelitis) Vaccines Sales in Volume by Region (2017-2022) & (K Units)
Table 29. Global Polio (Poliomyelitis) Vaccines Sales in Volume Forecast by Region (2023-2028) & (K Units)
Table 30. Global Polio (Poliomyelitis) Vaccines Sales in Value by Region (2017-2022) & (US$ Million)
Table 31. Global Polio (Poliomyelitis) Vaccines Sales in Value Forecast by Region (2023-2028) & (US$ Million)
Table 32. North America Polio (Poliomyelitis) Vaccines Sales in Volume by Country (2017-2028) & (K Units)
Table 33. North America Polio (Poliomyelitis) Vaccines Sales in Value by Country (2017-2028) & (US$ Million)
Table 34. Asia Pacific Polio (Poliomyelitis) Vaccines Sales in Volume by Region (2017-2028) & (K Units)
Table 35. Asia Pacific Polio (Poliomyelitis) Vaccines Sales in Value by Region (2017-2028) & (US$ Million)
Table 36. Europe Polio (Poliomyelitis) Vaccines Sales in Volume by Country (2017-2028) & (K Units)
Table 37. Europe Polio (Poliomyelitis) Vaccines Sales in Value by Country (2017-2028) & (US$ Million)
Table 38. Latin America Polio (Poliomyelitis) Vaccines Sales in Volume by Country (2017-2028) & (K Units)
Table 39. Latin Americaa Polio (Poliomyelitis) Vaccines Sales in Value by Country (2017-2028) & (US$ Million)
Table 40. Middle East and Africa Polio (Poliomyelitis) Vaccines Sales in Volume by Country (2017-2028) & (K Units)
Table 41. Middle East and Africa Polio (Poliomyelitis) Vaccines Sales in Value by Country (2017-2028) & (US$ Million)
Table 42. Sanofi Corporation Information
Table 43. Sanofi Description and Business Overview
Table 44. Sanofi Polio (Poliomyelitis) Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 45. Sanofi Polio (Poliomyelitis) Vaccines Product
Table 46. Sanofi Recent Development
Table 47. GSK Corporation Information
Table 48. GSK Description and Business Overview
Table 49. GSK Polio (Poliomyelitis) Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 50. GSK Product
Table 51. GSK Recent Development
Table 52. Bibcol Corporation Information
Table 53. Bibcol Description and Business Overview
Table 54. Bibcol Polio (Poliomyelitis) Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 55. Bibcol Product
Table 56. Bibcol Recent Development
Table 57. Serum Institute Corporation Information
Table 58. Serum Institute Description and Business Overview
Table 59. Serum Institute Polio (Poliomyelitis) Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 60. Serum Institute Product
Table 61. Serum Institute Recent Development
Table 62. Tiantan Biological Corporation Information
Table 63. Tiantan Biological Description and Business Overview
Table 64. Tiantan Biological Polio (Poliomyelitis) Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 65. Tiantan Biological Product
Table 66. Tiantan Biological Recent Development
Table 67. IMBCA Corporation Information
Table 68. IMBCA Description and Business Overview
Table 69. IMBCA Polio (Poliomyelitis) Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 70. IMBCA Product
Table 71. IMBCA Recent Development
Table 72. Panacea Biotec Ltd Corporation Information
Table 73. Panacea Biotec Ltd Description and Business Overview
Table 74. Panacea Biotec Ltd Polio (Poliomyelitis) Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 75. Panacea Biotec Ltd Product
Table 76. Panacea Biotec Ltd Recent Development
Table 77. Bio-Med Corporation Information
Table 78. Bio-Med Description and Business Overview
Table 79. Bio-Med Polio (Poliomyelitis) Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 80. Bio-Med Product
Table 81. Bio-Med Recent Development
Table 82. Halfkin Bio-Pharmaceuticals Corporation Information
Table 83. Halfkin Bio-Pharmaceuticals Description and Business Overview
Table 84. Halfkin Bio-Pharmaceuticals Polio (Poliomyelitis) Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 85. Halfkin Bio-Pharmaceuticals Product
Table 86. Halfkin Bio-Pharmaceuticals Recent Development
Table 87. Key Raw Materials Lists
Table 88. Raw Materials Key Suppliers Lists
Table 89. Polio (Poliomyelitis) Vaccines Customers List
Table 90. Polio (Poliomyelitis) Vaccines Distributors List
Table 91. Research Programs/Design for This Report
Table 92. Key Data Information from Secondary Sources
Table 93. Key Data Information from Primary Sources
List of Figures
Figure 1. Polio (Poliomyelitis) Vaccines Product Picture
Figure 2. Global Polio (Poliomyelitis) Vaccines Revenue, (US$ Million), 2017 VS 2022 VS 2028
Figure 3. Global Polio (Poliomyelitis) Vaccines Market Size 2017-2028 (US$ Million)
Figure 4. Global Polio (Poliomyelitis) Vaccines Sales 2017-2028 (K Units)
Figure 5. United States Polio (Poliomyelitis) Vaccines Revenue, (US$ Million), 2017 VS 2022 VS 2028
Figure 6. United States Polio (Poliomyelitis) Vaccines Market Size 2017-2028 (US$ Million)
Figure 7. United States Polio (Poliomyelitis) Vaccines Sales 2017-2028 (K Units)
Figure 8. United States Polio (Poliomyelitis) Vaccines Market Share in Global, in Value (US$ Million) 2017-2028
Figure 9. United States Polio (Poliomyelitis) Vaccines Market Share in Global, in Volume (K Units) 2017-2028
Figure 10. Polio (Poliomyelitis) Vaccines Report Years Considered
Figure 11. Product Picture of Inactivated Polio Vaccine (IPV)
Figure 12. Product Picture of Oral Polio Vaccine (OPV)
Figure 13. Global Polio (Poliomyelitis) Vaccines Market Share by Type in 2022 & 2028
Figure 14. Global Polio (Poliomyelitis) Vaccines Sales in Value by Type (2017-2028) & (US$ Million)
Figure 15. Global Polio (Poliomyelitis) Vaccines Sales Market Share in Value by Type (2017-2028)
Figure 16. Global Polio (Poliomyelitis) Vaccines Sales by Type (2017-2028) & (K Units)
Figure 17. Global Polio (Poliomyelitis) Vaccines Sales Market Share in Volume by Type (2017-2028)
Figure 18. Global Polio (Poliomyelitis) Vaccines Price by Type (2017-2028) & (USD/Unit)
Figure 19. United States Polio (Poliomyelitis) Vaccines Market Share by Type in 2022 & 2028
Figure 20. United States Polio (Poliomyelitis) Vaccines Sales in Value by Type (2017-2028) & (US$ Million)
Figure 21. United States Polio (Poliomyelitis) Vaccines Sales Market Share in Value by Type (2017-2028)
Figure 22. United States Polio (Poliomyelitis) Vaccines Sales by Type (2017-2028) & (K Units)
Figure 23. United States Polio (Poliomyelitis) Vaccines Sales Market Share in Volume by Type (2017-2028)
Figure 24. United States Polio (Poliomyelitis) Vaccines Price by Type (2017-2028) & (USD/Unit)
Figure 25. Product Picture of Research & Academic Laboratories
Figure 26. Product Picture of Pharmaceutical & Biotechnology Companies
Figure 27. Product Picture of Others
Figure 28. Global Polio (Poliomyelitis) Vaccines Market Share by Application in 2022 & 2028
Figure 29. Global Polio (Poliomyelitis) Vaccines Sales in Value by Application (2017-2028) & (US$ Million)
Figure 30. Global Polio (Poliomyelitis) Vaccines Sales Market Share in Value by Application (2017-2028)
Figure 31. Global Polio (Poliomyelitis) Vaccines Sales by Application (2017-2028) & (K Units)
Figure 32. Global Polio (Poliomyelitis) Vaccines Sales Market Share in Volume by Application (2017-2028)
Figure 33. Global Polio (Poliomyelitis) Vaccines Price by Application (2017-2028) & (USD/Unit)
Figure 34. United States Polio (Poliomyelitis) Vaccines Market Share by Application in 2022 & 2028
Figure 35. United States Polio (Poliomyelitis) Vaccines Sales in Value by Application (2017-2028) & (US$ Million)
Figure 36. United States Polio (Poliomyelitis) Vaccines Sales Market Share in Value by Application (2017-2028)
Figure 37. United States Polio (Poliomyelitis) Vaccines Sales by Application (2017-2028) & (K Units)
Figure 38. United States Polio (Poliomyelitis) Vaccines Sales Market Share in Volume by Application (2017-2028)
Figure 39. United States Polio (Poliomyelitis) Vaccines Price by Application (2017-2028) & (USD/Unit)
Figure 40. North America Polio (Poliomyelitis) Vaccines Sales in Volume Growth Rate 2017-2028 (K Units)
Figure 41. North America Polio (Poliomyelitis) Vaccines Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 42. U.S. Polio (Poliomyelitis) Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 43. Canada Polio (Poliomyelitis) Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 44. Europe Polio (Poliomyelitis) Vaccines Sales in Volume Growth Rate 2017-2028 (K Units)
Figure 45. Europe Polio (Poliomyelitis) Vaccines Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 46. Germany Polio (Poliomyelitis) Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 47. France Polio (Poliomyelitis) Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 48. U.K. Polio (Poliomyelitis) Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 49. Italy Polio (Poliomyelitis) Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 50. Russia Polio (Poliomyelitis) Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 51. Asia-Pacific Polio (Poliomyelitis) Vaccines Sales in Volume Growth Rate 2017-2028 (K Units)
Figure 52. Asia-Pacific Polio (Poliomyelitis) Vaccines Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 53. China Polio (Poliomyelitis) Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 54. Japan Polio (Poliomyelitis) Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 55. South Korea Polio (Poliomyelitis) Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 56. India Polio (Poliomyelitis) Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 57. Australia Polio (Poliomyelitis) Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 58. Taiwan Polio (Poliomyelitis) Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 59. Indonesia Polio (Poliomyelitis) Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 60. Thailand Polio (Poliomyelitis) Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 61. Malaysia Polio (Poliomyelitis) Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 62. Philippines Polio (Poliomyelitis) Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 63. Latin America Polio (Poliomyelitis) Vaccines Sales in Volume Growth Rate 2017-2028 (K Units)
Figure 64. Latin America Polio (Poliomyelitis) Vaccines Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 65. Mexico Polio (Poliomyelitis) Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 66. Brazil Polio (Poliomyelitis) Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 67. Argentina Polio (Poliomyelitis) Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 68. Middle East & Africa Polio (Poliomyelitis) Vaccines Sales in Volume Growth Rate 2017-2028 (K Units)
Figure 69. Middle East & Africa Polio (Poliomyelitis) Vaccines Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 70. Turkey Polio (Poliomyelitis) Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 71. Saudi Arabia Polio (Poliomyelitis) Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 72. U.A.E Polio (Poliomyelitis) Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 73. Polio (Poliomyelitis) Vaccines Value Chain
Figure 74. Polio (Poliomyelitis) Vaccines Production Process
Figure 75. Channels of Distribution
Figure 76. Distributors Profiles
Figure 77. Bottom-up and Top-down Approaches for This Report
Figure 78. Data Triangulation
Figure 79. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Sanofi GSK Bibcol Serum Institute Tiantan Biological IMBCA Panacea Biotec Ltd Bio-Med Halfkin Bio-Pharmaceuticals